Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Nancy Kassem"'
Autor:
Halima El Omri, Regina Padmanabhan, Ruba Y. Taha, Nancy Kassem, Hesham Elsabah, Anil Yousaf Ellahie, Antonio J.J. Santimano, Muna A. Al-Maslamani, Ali S. Omrani, Adel Elomri, Abdelfatteh El Omri
Publikováno v:
Journal of Infection and Public Health, Vol 17, Iss 1, Pp 152-162 (2024)
Background: The use of ill-suited antibiotics is a significant risk factor behind the increase in the mortality, morbidity, and economic burden for patients who are under treatment for hematological malignancy (HM) and bloodstream infections (BSI). S
Externí odkaz:
https://doaj.org/article/de080622001e4224b0cc8e309bdba180
Autor:
Hesham Elsabah, Halima El Omri, Elmukhtar Habas, Ruba Y. Taha, Sarah A. ElKourashy, Feryal Ibrahim, Abdulqadir J. Nashwan, Nancy Kassem, Laxmi Ojha, Rajvir Singh, Rola Ghasoub, Abdelfatteh El Omri
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundMultiple myeloma (MM) is one of the most common hematological malignancies globally, and it is projected to increase in the coming years. It occurs more frequently in males and affects older individuals. Presenting symptoms can range from b
Externí odkaz:
https://doaj.org/article/d3612795947545d28ef6dbfdd55556e2
Publikováno v:
Clinical Case Reports, Vol 11, Iss 11, Pp n/a-n/a (2023)
Key Clinical Message Erythema nodosum (EN) is a type of panniculitis occurring due to various conditions. It can be associated with certain malignancies or manifest as a side effect of drugs. This article presents a unique case of EN in a patient wit
Externí odkaz:
https://doaj.org/article/fbd8528b0f6848fdb1d89f264ef024e8
Publikováno v:
Clinical Case Reports, Vol 9, Iss 3, Pp 1228-1234 (2021)
Abstract Obesity may affect treatment outcome in CML patients, therefore the treatment of this cohort of patients need careful monitoring, TKIs dose adjustment may be required for certain patients. Further studies are needed to determine the proper T
Externí odkaz:
https://doaj.org/article/3bcd316d73764ac49ce503e9813414d5
Autor:
Mohammad Abu-Tineh, Nancy Kassem, Mohammad Abdul-Jaber Abdulla, Omar Mohammad Ismail, Khaldun Obeidat, Rola Ghasoub, Mohamed A. Yassin
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 1, Pp 291-294 (2020)
Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a myeloproliferative neoplasm characterized by increased proliferation of the granulocytic cell line without loss of its capacity to differentiate. It accounts for 20% of
Externí odkaz:
https://doaj.org/article/bb93c149e75c4249ad0af3d2f85c8cd9
Autor:
Mohammad Abu-Tineh, Nancy Kassem, Mohammad Abdul-Jaber Abdulla, Omar Mohammad Ismail, Rola Ghasoub, Mahmood B. Aldapt, Mohamed A. Yassin
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 1, Pp 336-340 (2020)
Myeloproliferative neoplasms are a diversified group of diseases of the hematopoietic stem cell, such as essential thrombocythemia (ET) and polycythemia vera. They are mainly caused by mutations in the following genes: JAK2, CALR, and MPL. All carry
Externí odkaz:
https://doaj.org/article/950a1ceaa12f463785ce0d5337abf4a4
Autor:
Shehab Fareed Mohamed, Awni Alshurafa, Dina Sameh Soliman, Halima El Omri, Deena Sideeg Mudawi, Mohamed A Yassin, Mohammad Afana, Hesham Elsabah, Anil Yousaf Ellahie, Nancy Kassem, Tareq Abuasab, Fadi Haddad, Samah Kohla, Aliaa Amer, Kalpana Singh, Honar Cherif
Publikováno v:
Blood. 140:11646-11648
Autor:
Shehab Fareed Mohamed, Yahya Mulikandathil, Dina Sameh Soliman, Feryal Abbas, Awni Alshurafa, Mohammad Afana, Anil Yousaf Ellahie, Deena Sideeg Mudawi, Halima El Omri, Amna Gameil, Tareq Abuasab, Fadi Haddad, Kalpana Singh, Nancy Kassem, Honar Cherif
Publikováno v:
Blood. 140:11651-11652
Autor:
Hawraa M Shwaylia, Nancy Kassem, Mahmood B Aldapt, Mohamed A. Yassin, Prem Chandra, Rola Ghasoub, Susanna Akiki, Abdulqadir J. Nashwan, Mohammad Abdul-Jaber Abdulla
Publikováno v:
Cancer Control, Vol 28 (2021)
Cancer Control : Journal of the Moffitt Cancer Center
Cancer Control : Journal of the Moffitt Cancer Center
The overall survival of patients with Chronic Myeloid Leukemia (CML) treated by using tyrosine kinase inhibitors (TKIs) is very close to that of the healthy population. However, little is known about the effect of specific measures such as intermitte
Autor:
Nancy, Kassem, Ahmed A, Ghazy, Mohammad, Abu-Tineh, Nabil E, Omar, Abdulqadir J, Nashwan, Prem, Chandra, Rola, Ghasoub, Osama S, AbuTabar, Mohamed A, Yassin
Publikováno v:
Medicine
Introduction: Existing evidence on the difference in the incidence of tumor lysis syndrome (TLS) in Chronic Lymphocytic Leukemia (CLL) patients receiving novel therapies versus patients receiving conventional therapies is limited and inconclusive. Th